GE Medical Systems offers an interactive glimpse of its AutoBone software for the Advantage Workstation at the 2003 RSNA meeting. The product enables clinicians to remove bone structure from diagnostic images.
GE Medical Systems offers an interactive glimpse of its AutoBone software for the Advantage Workstation at the 2003 RSNA meeting. The product enables clinicians to remove bone structure from diagnostic images.
AutoBone allows clinicians to see blood vessels that are otherwise hidden and optimizes surgical pathways with more precise information. It can minimize the invasiveness of certain procedures and increase diagnostic confidence, according to GE.
"Clinicians have the flexibility to see as much or as little of the transparent bone as they like and save hours of manual segmentation," said Jennifer Dible, GE Medical Systems general manager for Advantage Workstation.
Integration of the Advantage Workstation with Centricity PACS and is also being demonstrated in Chicago as a work-in-progress. Using the Centricity work list to drive workflow, radiologists and other users may have full use of the Advantage's broad array of clinical features without leaving the PACS viewing context, Dible said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.